Gateway
LLMPP Mission:
-
The Lymphoma/Leukemia Molecular Profiling Project is using Lymphochip cDNA
microarrays to define the gene expression profiles of all types of human
lymphoid malignancies. One primary goal of this Project is to redefine the
classification of human lymphoid malignancies in molecular terms. A second
major goal is to define molecular correlates of clinical parameters which
can be used in prognosis and in the selection of appropriate therapy for
these patients.
For questions concerning the Lymphoma/Leukemia Molecular Profiling Project, contact:
-
Louis Staudt, M.D., Ph.D. or John Chan, M.D. jchan@unmc.edu
- Website companion to Dave, S et al.
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tu
mor-Infiltrating Immune Cells
New England Journal of Medicine, Vol 351, 2159-2169 Nov 2004.
- Website companion to Wright, G et al.
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma
PNAS, Vol 100, 9991-9996, Aug 2003.
- Website companion to Rosenwald, A et al.
The proliferation gene expression signature is a quantitative integrator
of oncogenic events that predicts survival in mantle cell lymphoma.
Cancer Cell, Vol 3, 185-197, Feb 2003.
- Website companion to Rosenwald, A et al.
The Use of Molecular Profiling to Predict Survival after Chemotherapy
for Diffuse Large B-Cell Lymphoma.
New England Journal of Medicine, 346:1937-1947 (2002).
- Website companion to Rosenwald, A et al.
Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype
in B Cell Chronic Lymphocytic Leukemia.
The Journal of Experimental Medicine, 149:1639-1667 (2001).
- Website companion to Alizadeh et al. Distinct Types of Diffuse Large B-Cell Lymphoma Identified By Gene Expression Profiling. Nature 403: 503-511 (2000).
|